The Icahn School of Medicine at Mount Sinai, located in New York City, is one of the leading medical education and research institutions in the United States. With a rich history dating back to its establishment in 1968, the school has evolved into a global leader in medical education, biomedical research, and patient care.
History and Heritage
The school's origins trace back to the Mount Sinai Hospital, which was founded in 1852. The medical school was established to meet the growing need for physicians and scientists in an increasingly complex healthcare landscape. In 2012, the school received a transformative $200 million gift from Carl Icahn, a prominent financier and Mount Sinai trustee, leading to its renaming as the Icahn School of Medicine at Mount Sinai.
Educational Excellence
The Icahn School of Medicine is renowned for its innovative curriculum that emphasizes scientific discovery, clinical excellence, and compassionate care. The school offers a range of degree programs including MD, PhD, MD/PhD, master's, and certificate programs across various medical specialties and research disciplines.
Its unique approach to medical education focuses on early clinical exposure, small group learning, and integration of biomedical sciences with clinical practice. The school consistently ranks among the top medical schools in the nation for research funding, educational quality, and postgraduate residency placement.
Research and Innovation
As a major research institution, the Icahn School of Medicine is at the forefront of biomedical discovery. Its scientists and clinicians work collaboratively to translate laboratory findings into effective treatments and therapies. The school's research spans from basic science investigations to clinical trials and population health studies.
The institution is home to numerous research centers and institutes focusing on areas such as genomics and precision medicine, neurosciences, cardiovascular disease, cancer, immunology, and emerging infectious diseases. Researchers at Mount Sinai have made groundbreaking contributions to understanding the genetic basis of disease, developing novel therapeutic approaches, and advancing personalized medicine.
Clinical Integration
The Icahn School of Medicine is part of the Mount Sinai Health System, one of New York City's largest and most comprehensive healthcare networks. This integration provides students, researchers, and faculty unparalleled opportunities for clinical education, translational research, and patient care across diverse communities.
Mount Sinai Hospital, the flagship hospital of the system, consistently ranks among the nation's best hospitals in multiple specialties including cardiology, gastroenterology, neurology, oncology, and orthopedics, among others. The system includes eight hospital campuses, a renowned medical school, and a vast network of ambulatory practices.
Diversity and Inclusion
Committed to diversity, equity, and inclusion, the Icahn School of Medicine actively recruits and supports students, faculty, and staff from diverse backgrounds. The institution believes that diverse perspectives are essential for advancing medical knowledge, improving healthcare delivery, and addressing health disparities.
Through targeted pipeline programs, scholarships, mentorship initiatives, and inclusive policies, the school strives to create an environment where all individuals can thrive and contribute to the advancement of medicine and public health.
$982M+
Research Funding (2022)
#13
National NIH Funding Rank
1,500+
Faculty Researchers
450+
Active Clinical Trials
Global Impact
Beyond its local impact in New York City, the Icahn School of Medicine at Mount Sinai extends its influence globally through international research collaborations, educational partnerships, humanitarian initiatives, and global health programs. The institution addresses health challenges that transcend borders while training future leaders in global health.
Mount Sinai's global health initiatives include infectious disease surveillance, capacity building in resource-limited settings, medical education partnerships, and disaster response efforts. Its researchers and clinicians work to improve health outcomes worldwide by addressing both immediate health needs and systemic healthcare challenges.
Education Beyond Medicine
In addition to medical education, the Icahn School of Medicine offers graduate programs in biomedical sciences, public health, clinical research, genetic counseling, and other health professions. These programs prepare the next generation of scientists, healthcare leaders, and public health professionals with the knowledge and skills needed to address complex health challenges.
The school's commitment to interprofessional education ensures that graduates are prepared to work collaboratively across disciplines to improve patient outcomes, advance medical knowledge, and transform healthcare delivery systems.
Looking Forward
Under the leadership of Dr. Dennis S. Charney as President and Dr. Kenneth L. Davis as Chief Executive Officer, the Icahn School of Medicine at Mount Sinai continues to evolve and expand its impact on medical education, research, and patient care. With strategic investments in emerging fields such as artificial intelligence in medicine, digital therapeutics, and precision health, the institution is positioned to address the healthcare challenges of the 21st century.
By combining its rich heritage with innovative approaches, collaborative spirit, and commitment to excellence, the Icahn School of Medicine at Mount Sinai remains at the vanguard of medicine, educating future leaders who will transform healthcare and improve lives around the world.
